what metabolic is worth, page-9

I’ve already posted that I’m fairly bullish on MBP at the current price in relation to the risk of the ACV1 results so based on that I don’t actually see anything positive or negative in their latest announcement – just a neutral update. Some are probably over-analysing it too much looking for signs of positive results from the subtle use of language or second guessing why it is doing out to independent expert(s). Moot point really though as once it goes into a trading halt then all will be revealed and we will laugh or cry because of it. Surprised to see the SP drop last week and if it goes below my arbitrary price point of $0.12 I will happily buy more into the trial results release lead in.